GO Term | Evidence Code | PMID |
---|---|---|
negative regulation of membrane potential | ||
negative regulation of heterotypic cell-cell adhesion | ||
acute-phase response | ||
response to glucocorticoid | ||
insulin secretion |
GO Term | Evidence Code | PMID |
---|---|---|
extracellular space | ||
extracellular region | ||
centrosome | ||
nucleoplasm | ||
cytosol |
GO Term | Evidence Code | PMID |
---|---|---|
interleukin-1, type I receptor binding | ||
interleukin-1 receptor antagonist activity | ||
interleukin-1 type I receptor antagonist activity | ||
interleukin-1, type II receptor binding | ||
interleukin-1 type II receptor antagonist activity |
DO ID | Disease Name | Source |
---|---|---|
DOID:2921 | glomerulonephritis | |
DOID:2942 | bronchiolitis | |
DOID:2957 | pulmonary tuberculosis | |
DOID:2986 | IgA glomerulonephritis | |
DOID:3021 | acute kidney failure | |
DOID:3082 | interstitial lung disease | |
DOID:3083 | chronic obstructive pulmonary disease | |
DOID:3525 | middle cerebral artery infarction | |
DOID:3770 | pulmonary fibrosis | |
DOID:3904 | bronchus carcinoma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.1.1
Last updated: February 17, 2025